New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations
CINCINNATI–(BUSINESS WIRE)–National Resilience (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced long-term debt financing of up to $825 million from Oak Hill Advisors (OHA) to strengthen its balance sheet and fuel its growth plans. This new capital will enable Resilience to accelerate its CDMO business strategy and invest in its go-forward manufacturing operations anchored in Cincinnati and Toronto.
This financing underscores Resilience’s critical role as a CDMO manufacturing sterile drugs at scale and on shore. OHA brings more than three decades of investment experience and a proven track record of supporting growth in the life sciences sector. Resilience remains focused on high-growth segments in the biopharmaceutical market to advance cell-based medicines, primarily biologics, and aseptic drug product operations. The company is in the process of expanding its Cincinnati facility into one of the largest, most advanced sterile injectable and device assembly and packaging operations in North America.
